Celldex Stock Surge 28% On A Promising New Hives TreatmentCelldex Therapeutics ( NASDAQ:CLDX ) has recently emerged as a frontrunner in this arena, unveiling compelling results from its innovative treatment for chronic hives. The consequential findings have ignited a surge in investor enthusiasm, propelling the biotech stock to its highest point since Octo